CLMT Maintained by TD Cowen -- Price Target Raised to $40.00

TD Cowen has maintained a "Hold" rating for Calumet (CLMT) but raised its price target from $34.00 to $40.00. Despite this, GuruFocus assesses CLMT as significantly overvalued with a GF Value™ of $18.19 against its current price of $47.12. Insider selling totaling $20.6 million further suggests caution for investors, despite moderate GF Score™ indicating some profitability and growth strengths.